These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
462 related items for PubMed ID: 19575895
41. Role of blood and bone marrow examination in the diagnosis of mature lymphoid neoplasms in patients presenting with isolated splenomegaly. Sreedharanunni S, Sachdeva MU, Malhotra P, Ahluwalia J, Naseem S, Prakash G, Khadwal A, Sharma P, Kumar N, Varma N, Varma S, Das R. Hematology; 2015 Oct; 20(9):530-7. PubMed ID: 25760312 [Abstract] [Full Text] [Related]
42. Absence of cyclin D1 protein expression in splenic marginal zone lymphoma. Savilo E, Campo E, Mollejo M, Pinyol M, Piris MA, Zukerberg LR, Yang WI, Koelliker DD, Nguyen PL, Harris NL. Mod Pathol; 1998 Jul; 11(7):601-6. PubMed ID: 9688179 [Abstract] [Full Text] [Related]
43. [Gastrointestinal B-cell lymphoma: a morphologic and immunohistochemical study of 194 cases]. He S, Guo Y, Bei CF, Dai YZ, Zhu DB, Li CS, Zhu XH, LE MZ. Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):814-8. PubMed ID: 21215096 [Abstract] [Full Text] [Related]
45. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. Camacho FI, Mollejo M, Mateo MS, Algara P, Navas C, Hernández JM, Santoja C, Solé F, Sánchez-Beato M, Piris MA. Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461 [Abstract] [Full Text] [Related]
46. Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia. Xing KH, Kahlon A, Skinnider BF, Connors JM, Gascoyne RD, Sehn LH, Savage KJ, Slack GW, Shenkier TN, Klasa R, Gerrie AS, Villa D. Br J Haematol; 2015 May; 169(4):520-7. PubMed ID: 25854936 [Abstract] [Full Text] [Related]
47. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification. Traverse-Glehen A, Baseggio L, Salles G, Felman P, Berger F. Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505 [Abstract] [Full Text] [Related]
56. Distinct morphologic, phenotypic, and clinical-course characteristics of indolent peripheral T-cell lymphoma. Hayashi E, Takata K, Sato Y, Tashiro Y, Tachiyama Y, Sawada-Kitamura S, Hiramatsu Y, Sugiguchi S, Nose S, Hirokawa M, Ando M, Abd Alkader L, Maeda Y, Tanimoto M, Yoshino T. Hum Pathol; 2013 Sep; 44(9):1927-36. PubMed ID: 23706909 [Abstract] [Full Text] [Related]
57. How to treat splenic marginal zone lymphoma (SMZL) in patients unfit for surgery or more aggressive therapies: experience in 30 cases. Cervetti G, Ghio F, Cecconi N, Morganti R, Galimberti S, Petrini M. J Chemother; 2017 Apr; 29(2):126-129. PubMed ID: 27454143 [Abstract] [Full Text] [Related]
58. Micronodular T-cell/histiocyte-rich large B-cell lymphoma of the spleen: histology, immunophenotype, and differential diagnosis. Dogan A, Burke JS, Goteri G, Stitson RN, Wotherspoon AC, Isaacson PG. Am J Surg Pathol; 2003 Jul; 27(7):903-11. PubMed ID: 12826882 [Abstract] [Full Text] [Related]